Matti Hero Selected Research

Matti Hero Research Topics

4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 05/2012
4	Congenital Abnormalities (Deformity) 01/2019 - 01/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2020
2	Precocious Puberty 01/2021 - 10/2011
2	Hyperandrogenism 10/2011 - 11/2006
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 10/2011 - 09/2005
2	Growth Disorders 07/2010 - 09/2006
1	Obesity 03/2022
1	Hypopituitarism (Sheehan's Syndrome) 01/2020
1	Combined Pituitary Hormone Deficiency 01/2020
1	Penis agenesis 12/2018
1	Gingival Fibromatosis 01/2018
1	Amenorrhea 01/2017
1	Craniopharyngioma (Craniopharyngiomas) 01/2017
1	Gynecomastia 10/2011
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2011
1	Familial Testotoxicosis 10/2011
1	Breast Neoplasms (Breast Cancer) 10/2011
1	Ovarian Cysts (Ovarian Cyst) 10/2011
1	Polycythemia (Erythrocytosis) 10/2011
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 10/2011
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2011
1	Osteoporosis 01/2011
1	Compression Fractures (Compression Fracture) 07/2010
1	Bone Resorption 01/2009
1	Klinefelter Syndrome (Klinefelter's Syndrome) 11/2006
1	Insulin Resistance 09/2006
1	Perinatal Death 03/2005
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2005

4	Aromatase InhibitorsIBA 10/2011 - 09/2006
4	Letrozole (Femara)FDA LinkGeneric 10/2011 - 11/2006
2	Growth Hormone (Somatotropin)IBA 01/2020 - 01/2018
2	Hormones (Hormone)IBA 01/2020 - 05/2012
2	Human Follicle Stimulating HormoneIBA 01/2019 - 12/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017 - 01/2017
2	inhibin BIBA 01/2017 - 05/2012
1	Ghrelin ReceptorsIBA 03/2022
1	Antimicrobial PeptidesIBA 03/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2018
1	GonadotropinsIBA 01/2017
1	HDL CholesterolIBA 10/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 10/2011
1	due to increased aromatase activity familial gynecomastiaIBA 10/2011
1	Diphosphonates (Bisphosphonates)IBA 01/2011
1	Zoledronic Acid (Zometa)FDA Link 01/2011
1	Pamidronate (Aredia)FDA LinkGeneric 01/2011
1	Estrogens (Estrogen)FDA Link 07/2010
1	N-propeptide type I collagenIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	Alkaline PhosphataseIBA 01/2009
1	Collagen Type I (Type I Collagen)IBA 01/2009
1	Insulin (Novolin)FDA Link 11/2006
1	Aromatase (CYP19)IBA 09/2006
1	AndrogensIBA 09/2006
1	AdiponectinIBA 09/2006
1	Flutamide (Eulexin)FDA LinkGeneric 09/2005
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2005
1	GlucocorticoidsIBA 03/2005